Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF): a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) Buch/Monographie |
| Sprache: | Englisch |
| Veröffentlicht: |
London
BioMed Central
2017
|
| DOI: | 10.1186/s12890-017-0462-y |
| Online-Zugang: | Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12890-017-0462-y Resolving-System, kostenfrei, Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-234946 
|
| Verfasserangaben: | Jürgen Behr; Petra Neuser; Antje Prasse; Michael Kreuter; Klaus Rabe; Carmen Schade-Brittinger; Jasmin Wagner; Andreas Günther |
MARC
| LEADER | 00000cam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1656484811 | ||
| 003 | DE-627 | ||
| 005 | 20230426090004.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 171017s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a urn:nbn:de:bsz:16-heidok-234946 |2 urn | |
| 024 | 7 | |a 10.1186/s12890-017-0462-y |2 doi | |
| 035 | |a (DE-627)1656484811 | ||
| 035 | |a (DE-576)494474394 | ||
| 035 | |a (DE-599)BSZ494474394 | ||
| 035 | |a (OCoLC)1010426933 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Behr, Jürgen |d 1960- |e VerfasserIn |0 (DE-588)173666701 |0 (DE-627)674755634 |0 (DE-576)134508963 |4 aut | |
| 245 | 1 | 0 | |a Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) |b a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial |c Jürgen Behr; Petra Neuser; Antje Prasse; Michael Kreuter; Klaus Rabe; Carmen Schade-Brittinger; Jasmin Wagner; Andreas Günther |
| 264 | 1 | |a London |b BioMed Central |c 2017 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Aus: BMC Pulmonary Medicine, 17 (2017), Nr. 122. pp. 1-9. ISSN 1471-2466 | ||
| 700 | 1 | |a Prasse, Antje |d 1969- |e VerfasserIn |0 (DE-588)124557589 |0 (DE-627)363419853 |0 (DE-576)186206739 |4 aut | |
| 700 | 1 | |a Kreuter, Michael |d 1972- |e VerfasserIn |0 (DE-588)122645995 |0 (DE-627)082066795 |0 (DE-576)293362742 |4 aut | |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12890-017-0462-y |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-234946 |q application/pdf |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a BO | ||
| 992 | |a 20171017 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 122645995 |a Kreuter, Michael |m 122645995:Kreuter, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PK122645995 |e 950000PK122645995 |e 950900PK122645995 |e 50000PK122645995 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 4 | ||
| 999 | |a KXP-PPN1656484811 |e 3388146349 | ||
| BIB | |a Y | ||
| JSO | |a {"name":{"displayForm":["Jürgen Behr; Petra Neuser; Antje Prasse; Michael Kreuter; Klaus Rabe; Carmen Schade-Brittinger; Jasmin Wagner; Andreas Günther"]},"origin":[{"publisher":"BioMed Central","dateIssuedDisp":"2017","dateIssuedKey":"2017","publisherPlace":"London"}],"id":{"uri":["urn:nbn:de:bsz:16-heidok-234946"],"doi":["10.1186/s12890-017-0462-y"],"eki":["1656484811"]},"physDesc":[{"extent":"1 Online-Ressource"}],"person":[{"display":"Behr, Jürgen","given":"Jürgen","roleDisplay":"VerfasserIn","role":"aut","family":"Behr"},{"family":"Prasse","role":"aut","roleDisplay":"VerfasserIn","given":"Antje","display":"Prasse, Antje"},{"family":"Kreuter","given":"Michael","role":"aut","roleDisplay":"VerfasserIn","display":"Kreuter, Michael"}],"language":["eng"],"title":[{"subtitle":"a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial","title_sort":"Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF)","title":"Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF)"}],"type":{"media":"Online-Ressource","bibl":"book"},"note":["Aus: BMC Pulmonary Medicine, 17 (2017), Nr. 122. pp. 1-9. ISSN 1471-2466"],"recId":"1656484811"} | ||
| SRT | |a BEHRJUERGEEXPLORINGE2017 | ||